Literature DB >> 6097641

Analysis and detection of chlamydial DNA.

T Hyypiä, S H Larsen, T Ståhlberg, P Terho.   

Abstract

Elementary bodies of lymphogranuloma venereum (LGV) strains of Chlamydia trachomatis contain, in addition to the genomic DNA, a 6.7 kb plasmid. The plasmid from serovar L2 (434-B) was cloned at the BamHI site of pBR327 into Escherichia coli and a restriction cleavage map of this pLGV125 recombinant plasmid determined. All 15 C. trachomatis serovars contained DNA sequences that hybridized with pLGV125. When total DNA from L2 elementary bodies was used as a probe in Southern blotting and spot hybridization, serovars L1, L2 and L3 exhibited significant homology. The detection level of homologous DNA was 100 pg and LGV DNA was detectable in infected cells when total L2 probe was used in the nucleic acid hybridization test. These DNA probes may be useful as investigative and diagnostic reagents for C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097641     DOI: 10.1099/00221287-130-12-3159

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  13 in total

Review 1.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

2.  Comparison of Chlamydia psittaci isolates by restriction endonuclease and DNA probe analyses.

Authors:  P Timms; F W Eaves; A A Girjes; M F Lavin
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Detection of C trachomatis in urogenital specimens by polymerase chain reaction.

Authors:  H Näher; H Drzonek; J Wolf; M von Knebel Doeberitz; D Petzoldt
Journal:  Genitourin Med       Date:  1991-06

4.  Chlamydia trachomatis detected in human placenta.

Authors:  M Gencay; M Puolakkainen; T Wahlström; P Ammälä; L Mannonen; A Vaheri; M L Koskiniemi
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

5.  Comparison of nucleic acid hybridization with enzyme immunoassay and isolation for detection of Chlamydia trachomatis.

Authors:  H Tuokko; P Ruuska; T Hyypiä
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

6.  DNA probes for clinical applications. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-06       Impact factor: 2.926

7.  Detection of plasmid DNA from all Chlamydia trachomatis serovars with a two-step polymerase chain reaction.

Authors:  D Welch; C H Lee; S H Larsen
Journal:  Appl Environ Microbiol       Date:  1990-08       Impact factor: 4.792

Review 8.  Clinical laboratory applications of monoclonal antibodies.

Authors:  W J Payne; D L Marshall; R K Shockley; W J Martin
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

9.  Molecular characterization of Chlamydia trachomatis and Chlamydia psittaci plasmids.

Authors:  T Joseph; F E Nano; C F Garon; H D Caldwell
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

10.  Deoxyribonucleic acid amplification and hybridisation in Crohn's disease using a chlamydial plasmid probe.

Authors:  B H McGarity; D A Robertson; I N Clarke; R Wright
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.